Results 141 to 150 of about 367,561 (197)

Sertoli-Leydig Cell Tumour With Heterologous Elements Presenting as Hyperandrogenaemia and Markedly Elevated Alpha-Fetoprotein: A Challenging Diagnosis. [PDF]

Cureus
Albousen B, Mechery J.
europepmc   +1 more source

Utility of Ki-67 index combined with alpha-fetoprotein and lactate dehydrogenase in distinguishing mature from immature ovarian teratomas in children. [PDF]

Front Neurol
Li X, Zhong Z, Qi Y, Gong Y.
europepmc   +1 more source

Incidentally Detected Ovarian Teratoma on Fluorodeoxyglucose (FDG) PET/CT Scanning in a Patient With Gastric Cancer. [PDF]

Cureus
Vatankulu B, Yilmaz S.
europepmc   +1 more source

CT- and MR Imaging-based Radiomics Approach to Differentiating Ovarian Mature and Immature Teratomas: Can MR Imaging-based Radiomics Predict the Histological Grade of Immature Teratomas? [PDF]

Magn Reson Med Sci
Maeda T, Kato H, Furui T, Isobe M, Kawamura T, Nishibori H, Kawaguchi M, Noda Y, Elhelaly AE, Imai H, Matsuo M.   +10 more
europepmc   +1 more source

Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2023 and Annual Treatment Report for 2018. [PDF]

J Obstet Gynaecol Res
Kajiyama H, Tamauchi S, Takahashi F, Satoh T, Board members of the 2025 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology.   +4 more
europepmc   +1 more source

[Chemotherapy of immature ovarian teratomas].

Ginekologia polska, 1984
openaire   +1 more source

Immature teratoma of the ovary with microscopic yolk sac tumor in children and adolescents: A multi-institutional study. [PDF]

Gynecol Oncol
Rich BS, Fishbein JS, Purcell LN, Murphy JT, Castle SL, Ghanbari N, Zohrabian A, Lautz TB, Kacey W, Post G, Thangarajah H, West E, Roach JP, Corkum KS, Perry T, Piché N, Roy M, Stafman LL, Dixon SM, Glithero KJ, Pittman ME, Çeliker MY, Grant CN, Sharf T, Tracy ET, Wachsmuth LP, Rustad A, Newman EA, Williams K, Wunker CM, Glick RD, Dasgupta R, Wilson S, Vore E, Cromeens BP, Turk F, Shaffiey SA, Alkhoury F, Goyal J, Brown EG, Seemann NM, Wilson CA, Davidson J, Polites SF, Parrish MT, Cameron DB, Stetson A, Gold RM, Aldrink JH, Mansfield SA, Srivatsa S, Christison-Lagay E, Rehman SU, Fialkowski EA, Selesner L, Larsen A, Le HD, Tracy SA, Ahmed T, Dimmer A, Malek MM, Campwala I, Colangelo A, Rothstein DH, Nchinda NN, Mattei P, Jain S, Hwang R, Craig BT, Lal DR, Abrebese E, Rhee DS, Chidiac C, Peters M, Boehmer C, Billmire DF.   +75 more
europepmc   +1 more source

Clinical outcomes of a 3-day modified BEP regimen in malignant ovarian germ cell tumors in a single-center real-world study. [PDF]

World J Surg Oncol
Zhang X, Ren Y, Liang Y, Wang L, Wang Y, Chen Y, Xu J.   +6 more
europepmc   +1 more source

Clinical Features of Malignant Ovarian Germ Cell Tumors According to Demographic and Pathologic Characteristics. [PDF]

Health Sci Rep
Agah J, Navipour E, Akhavan S, Norouzi S.   +3 more
europepmc   +1 more source

Malignant Ovarian Germ Cell Tumor-Survival and Reproductive Outcomes and Patterns of Relapse. [PDF]

Cancer Med
Dey S, Anne S, Rath S, Nandhana R, Gulia S, Dash B, Menon S, Rekhi B, Baheti A, Sable N, Popat P, Tandon S, Ghosh K, Gurram L, Parab SS, Logkumer AN, Jhadhav S, Chopra S, Surappa ST, Bansal V, Balsarkar G, Deodhar K, Maheshwari A, Ghosh J, Gupta S.   +24 more
europepmc   +1 more source